Phosphorus Additives and Their Impact on Phosphorus Content in Foods-An Analysis of the USDAs Branded Foods Product Database.


Journal

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
ISSN: 1532-8503
Titre abrégé: J Ren Nutr
Pays: United States
ID NLM: 9112938

Informations de publication

Date de publication:
05 2023
Historique:
received: 08 10 2022
revised: 15 12 2022
accepted: 17 12 2022
medline: 26 5 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

The frequency of phosphate additives reported in the United States Department of Agriculture Branded Foods Product Database and how these additives impact phosphate content is unknown. All products included in the Branded Foods Product Database reporting phosphorus content were reviewed for presence of phosphate salts and/or lecithin additives. Phosphorus content information was available for 3,466 (1.45%) food items, of these 1791 (51.6%) contained additives. Median phosphorus content was lowest in products with lecithin only compared to products without phosphorus additives (86 [54-200] vs. 145 [77-351] mg per 100 g, P < .01), which was not different from products with phosphate salts (176 [101-276] mg per 100 g, P = .22) or products with both phosphate salts and lecithin (161 [99-285] mg per 100 g, P = 1.00). The impact of a phosphorus salt on phosphorus content (mg per 100) was explored among ultra-processed products grouped by similar phosphorus contents. The phosphorus content of in in nondairy alternatives, dairy, plant proteins, and grains were significantly higher when the product contained a phosphate salt compared to products without a phosphate salt. For all products phosphorus and potassium content were correlated, but the relationship was stronger for when a potassium phosphate additive was present compared to absent (rho = 0.81 vs. 0.53, P < .05). Similar patterns were seen for sodium, calcium, and iron with stronger correlations with phosphate content for products with additives than those without (calcium phosphate: rho = 0.47 vs. 0.32; iron phosphate: rho = 0.47 vs. 0.33; sodium phosphate: rho = 0.45 vs. 0.07. All P < .05). The relationship between phosphate and sodium for products without phosphate additives was weak. Lecithin may not be associated with increased phosphorus content. Calcium, potassium, sodium, and iron phosphorus salts appear to be associated with increases in the composite mineral and phosphorus content, with the strongest correlation between potassium and phosphorus content.

Identifiants

pubmed: 36731685
pii: S1051-2276(23)00008-0
doi: 10.1053/j.jrn.2022.12.007
pii:
doi:

Substances chimiques

Phosphorus 27YLU75U4W
Food Additives 0
Phosphorus, Dietary 0
Calcium SY7Q814VUP
Lecithins 0
Salts 0
Phosphates 0
Sodium 9NEZ333N27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-449

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Kelly Picard (K)

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.

Melanie Griffiths (M)

Alberta Kidney Care - North, Alberta Health Services, Edmonton, Alberta, Canada.

Peter A Senior (PA)

Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Diana R Mager (DR)

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.

Caroline Richard (C)

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada. Electronic address: cr5@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH